Missing doses or stopping denosumab without a follow-on medication can cause rapid bone loss and spine fractures. Keep every six-month dose on schedule.
Denosumab is an antibody that slows the cells that break down bone. It is given as an injection every six months to prevent and treat osteoporosis, including the bone loss caused by long-term steroids. Prolia and its biosimilars (such as Jubbonti) are the same medicine and are used the same way; in Canada the biosimilar is now often the covered option.
Reduces spine and hip fractures, including with steroid-related bone loss.
A simple injection every six months.
Can be used when bisphosphonates are not suitable, including in reduced kidney function.
No empty-stomach or stay-upright rules, unlike oral bisphosphonates.
Your doctor prescribed this because the expected benefits outweigh the risks for your situation. Here is the honest, full picture.
Denosumab’s effect fades after about six months. Missing a dose or stopping without another bone medication to follow can cause fast bone loss and multiple spine fractures. Keep every dose on schedule, and if it is ever stopped, your doctor will start a bridging medication.
Denosumab is avoided in pregnancy, and effective contraception is advised during treatment. Tell your doctor if you are pregnant or planning, so bone protection can be reviewed.
This guide is for education, not medical advice. Myositis treatment is individual, and many of these medications are used based on specialist experience and evidence rather than a formal Canadian myositis indication. Never start, stop, or change a medication without your own doctor. Your doses and choices are decided with your care team at the Centre.